This association was strongly apparent in multiple tumor types that have a high frequency of SETD2 mutations, in addition to lung adenocarcinoma (Fig. 1A and Supplementary Fig. 1A–D)18. This evidence concerns the gene SETD2 and lung adenocarcinoma.